Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
The approval marks an important advancement in hereditary angioedema prevention therapies.
Read More
Featuring the latest pharmacy industry news and reports curated from trusted sources, including the NHS, MHRA, and other recognized healthcare bodies.
The approval marks an important advancement in hereditary angioedema prevention therapies.
Read More
New healthcare recommendations focus on improving medicine safety and patient awareness.
Read More
Updated guidance helps pharmacies understand inspection expectations and regulatory standards.
Read More
Regulatory reforms are expected to improve access to treatments for rare diseases.
Read More
Industry leaders urge reconsideration of pharmacy business rate increases impacting independent pharmacies.
Read More
Faster assessments and agile regulation aim to improve healthcare innovation across the UK.
Read MoreWe help you scale with AI, Automation, and Digital Pharma Solutions tailored for your unique business needs.